Bionova Scientific
Bionova Scientific partners with innovators in the biologic industry to bring life-changing therapies to market. Founded in 2014 and acquired by Asahi Kasei Group in 2022, Bionova Scientific offers customers access to superior tools and technologies and an unwavering commitment to quality delivered with scientific excellence across the entire lifecycle. Bionova offers integrated CDMO services that span cell line development, process development to commercial cGMP manufacturing of complex proteins and antibodies. Our experienced scientists bring proven expertise to overcoming discovery to first-in-human development challenges and scale-up. Bionova is a flexible and collaborative partner that has worked with leading biotechnology innovators from its new state-of-the-art facility in the San Francisco Bay Area. For more information, visit bionovascientific.comContent by Bionova Scientific
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
| 2 min read
Cytiva’s Fast Trak process development services will accelerate Bionova’s production processes while ensuring compliance with stringent regulatory standards
Page 1 of 1 - 2 Total Items
